Cover Image
市場調查報告書

全球乳癌市場

Global Breast Cancer Market: Industry Analysis & Outlook 2017-2021

出版商 Koncept Analytics 商品編碼 204467
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
全球乳癌市場 Global Breast Cancer Market: Industry Analysis & Outlook 2017-2021
出版日期: 2017年02月03日 內容資訊: 英文 70 Pages
簡介

乳癌,是最常診斷出的癌症,是女性癌症的死亡原因的第1名。乳癌最常見的危險因素,是女性和老齡化。

本報告提供全球乳癌診斷、治療市場相關調查分析,以美國、巴西、歐洲、亞太地區為焦點,提供市場動態,成長推動因素與課題、競爭情形、主要企業等相關的系統性資訊。

第1章 市場概要

  • 乳癌
  • 乳癌的種類
  • 危險因素
  • 乳癌的症狀
  • 乳癌的診斷和治療
    • 乳癌的檢驗、診斷法
    • 乳癌的治療方法

第2章 乳癌市場

  • 全球市場
    • 診斷市場
    • 治療市場
    • 市場區隔

第3章 地區市場

  • 美國
  • 巴西
  • 亞太地區
  • 歐洲

第4章 市場動態

  • 產業的發展
  • 成長推動因素
  • 課題

第5章 競爭情形

  • 醫藥品比較
  • 淨利
  • R&D預算

第6章 企業簡介

  • 產業概要、財務概要、產業策略
    • Johnson & Johnson
    • Hologic, Inc.
    • Roche
    • Novartis
    • Siemens AG

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

'Breast cancer' defines a malignant tumor that has developed from cells in the breast. Some breast cancers are called in situ as they are confined within the ducts (ductal carcinoma in situ or DCIS) or lobules (lobular carcinoma in situ or LCIS) where they originated. Although, less commonly, breast cancer can also instigate in the stromal tissues, which include the fatty and fibrous connective tissues of the breast. In the early stages, breast cancer may not cause any symptoms. A lump may be too small to feel or to cause any unusual changes that could be noticed on own. Typically, an abnormal area shows up on a screening mammogram which leads to further testing. Several risk factors including smoking and alcohol consumption, exposure to estrogen, gender, age, radiation therapy, family history and personal history are linked to the growth of breast cancer.

The global market for breast cancer has grown swiftly over the past few years driven by introduction of several new drugs and biosimilars. The overall breast cancer market remained mainly dominated by the generic drugs. The future market for breast cancer will grow in the coming years as there exist unmet need for new drugs that would overcome resistance and prevent recurrence of the disease.

The global breast cancer market is likely to grow strongly in the coming years driven by rising healthcare expenditure, rising diabetic and obese population, increased spending on medicines, increasing consumption of alcohol and tobacco and rising female population above 65 years of age. Key trends of the market includes rising development of PARP inhibitors, clinical trials of CDK4/6 inhibitors and introduction of new imaging tests. However, growth of the market can be hindered by several factors including drug development challenges in developing countries, long term side effects of drugs and heavy costs associated with drug development.

The report "Global Breast Cancer Market: Industry Analysis & Outlook (2017-2021)" by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S., Europe and APAC regions along with the global market. The report profiles the key players of the market including Johnson & Johnson, AbbVie, AstraZeneca and Roche.

Table of Contents

1. Introduction

  • 1.1 Market Overview

2. Global Breast Cancer Market

  • 2.1 Global Breast Cancer Market by Value
  • 2.2 Global Breast Cancer Market Forecast by Value
  • 2.3 Global Breast Cancer Market by Region
  • 2.4 Global Breast Cancer Drug Development by Stages

3. Regional Breast Cancer Market

  • 3.1 The U.S.
    • 3.1.1 The U.S. Breast Cancer Market by Value
    • 3.1.2 The U.S. Breast Cancer Market Forecast by Value
    • 3.1.3 The U.S. Breast Cancer Market by Addressable Population
    • 3.1.4 The U.S. Breast Cancer Market Forecast by Addressable Population
    • 3.1.5 The U.S. Breast Cancer Population by Age
  • 3.2 Europe
    • 3.2.1 EU5 Breast Cancer Market by Value
    • 3.2.2 EU5 Breast Cancer Market Forecast by Value
  • 3.3 APAC
    • 3.3.1 APAC Breast Cancer Market by Value
    • 3.3.2 APAC Breast Cancer Market Forecast by Value
    • 3.3.3 APAC Breast Cancer Market by Countries
    • 3.3.4 Japan's Breast Cancer Market by Value
    • 3.3.5 Japan's Breast Cancer Market Forecast by Value
    • 3.3.6 China's Breast Cancer Market by Value
    • 3.3.7 China's Breast Cancer Market Forecast by Value
    • 3.3.8 Australia's Breast Cancer Market by Value
    • 3.3.9 Australia's Breast Cancer Market Forecast by Value

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Rising Consumption of Tobacco and Alcohol
    • 4.1.2 Increasing Global Diabetic Population
    • 4.1.3 Increasing Obesity
    • 4.1.4 Increasing Healthcare Expenditure Per Capita
    • 4.1.5 Rising Female Population Aged 65 Years & Above
    • 4.1.6 Global Spending on Medicines
  • 4.2 Key Trends & Developments
    • 4.2.1 PARP Inhibitors under Development
    • 4.2.2 CDK4/6 Inhibitors Under Clinical Trials for Breast Cancer
    • 4.2.3 Introduction of Newer Imaging Tests
  • 4.3 Challenges
    • 4.3.1 Long Term Side Effects
    • 4.3.2 Drug Development Challenges in Developing Countries
    • 4.3.3 Heavy Drug Developmental Costs

5. Competition

  • 5.1 Revenue Comparison
  • 5.2 Research & Development Expenditure Comparison
  • 5.3 Market Cap Comparison

6. Company Profiles

  • 6.1 Johnson & Johnson
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 AstraZeneca
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 AbbVie
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies
  • 6.4 Roche
    • 6.4.1 Business Overview
    • 6.4.2 Financial Overview
    • 6.4.3 Business Strategies

List of Charts

  • Breast Cancer by Types
  • Stages of Breast Cancer
  • Global Breast Cancer Market by Value (2012-2016)
  • Global Breast Cancer Market Forecast by Value (2017-2021)
  • Global Breast Cancer Market by Region (2016)
  • Global Breast Cancer Drug Development by Stages (2016)
  • The U.S. Breast Cancer Market by Value (2012-2016)
  • The U.S. Breast Cancer Market Forecast by Value (2017-2021)
  • The U.S. Breast Cancer Market by Addressable Population (2012-2016)
  • The U.S. Breast Cancer Market Forecast by Addressable Population (2017-2021)
  • The U.S. Breast Cancer Population by Age & Type (2016)
  • EU5 Breast Cancer Market by Value (2012-2016)
  • EU5 Breast Cancer Market Forecast by Value (2017-2021)
  • APAC Breast Cancer Market by Value (2012-2016)
  • APAC Breast Cancer Market Forecast by Value (2017-2021)
  • APAC Breast Cancer Market by Countries (2016)
  • Japan's Breast Cancer Market by Value (2012-2016)
  • Japan's Breast Cancer Market Forecast by Value (2017-2021)
  • China's Breast Cancer Market by Value (2012-2016)
  • China's Breast Cancer Market Forecast by Value (2017-2021)
  • Australia's Breast Cancer Market by Value (2012-2016)
  • Australia's Breast Cancer Forecast Market by Value (2017-2021)
  • Global Cigarette Consumption (1990-2016E)
  • Global Diabetic Population (2012-2016E)
  • Global Obese Population (2012-2016E)
  • Global Healthcare Expenditure Per Capita (2012-2016E)
  • Global Female Population Aged 65 Years and Above (2015-2050E)
  • Global Spending on Medicines (2007-2017E)
  • Key PARP Inhibitors under Development (2016)
  • Key CDK4/6 Inhibitors Clinical Status for Breast Cancer (2016)
  • Key Players Revenue Comparison (2015)
  • Key Players R&D Expenditure (2015)
  • Key Players Market Cap Comparison (2016)
  • Johnson & Johnson Sales by Segments (2016*)
  • J&J Revenue (2010-2015)
  • AstraZeneca Product Sales by Region (2015)
  • AstraZeneca Revenue and Profit (2012-2015)
  • AstraZeneca Development Pipeline Overview
  • AbbVie Net Revenue by Product Segments (2015)
  • AbbVie Net Revenues (2011-2015)
  • Roche Sales by Segments (2015)
  • Roche Sales and Net Income (2011-2015)
Back to Top